IT1250629B - Uso dei derivati dell'acido benzimidazolin-2-oxo-1-carbossilico. - Google Patents

Uso dei derivati dell'acido benzimidazolin-2-oxo-1-carbossilico.

Info

Publication number
IT1250629B
IT1250629B ITMI911845A ITMI911845A IT1250629B IT 1250629 B IT1250629 B IT 1250629B IT MI911845 A ITMI911845 A IT MI911845A IT MI911845 A ITMI911845 A IT MI911845A IT 1250629 B IT1250629 B IT 1250629B
Authority
IT
Italy
Prior art keywords
benzimidazolin
oxo
carboxylic acid
acid derivatives
dementia
Prior art date
Application number
ITMI911845A
Other languages
English (en)
Inventor
Marco Turconi
Alessandro Brambilla
Franco Borsini
Pierino Schiantarelli
Herbert Ladinsky
Original Assignee
Boehringer Ingelheim Italia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Italia filed Critical Boehringer Ingelheim Italia
Publication of ITMI911845A0 publication Critical patent/ITMI911845A0/it
Priority to ITMI911845A priority Critical patent/IT1250629B/it
Priority to CA002072911A priority patent/CA2072911A1/en
Priority to DK92830346.0T priority patent/DK0523013T3/da
Priority to DE69200948T priority patent/DE69200948T2/de
Priority to TW081105256A priority patent/TW202386B/zh
Priority to MX9203900A priority patent/MX9203900A/es
Priority to EP92830346A priority patent/EP0523013B1/en
Priority to AT92830346T priority patent/ATE115857T1/de
Priority to AU19381/92A priority patent/AU658197B2/en
Priority to JP4175281A priority patent/JPH05194216A/ja
Priority to IL102381A priority patent/IL102381A0/xx
Priority to ZA924949A priority patent/ZA924949B/xx
Priority to IE217492A priority patent/IE922174A1/en
Priority to KR1019920011823A priority patent/KR930001906A/ko
Priority to HU9202229A priority patent/HUT61462A/hu
Priority to NO92922635A priority patent/NO922635L/no
Publication of ITMI911845A1 publication Critical patent/ITMI911845A1/it
Priority to GR950400566T priority patent/GR3015413T3/el
Application granted granted Critical
Publication of IT1250629B publication Critical patent/IT1250629B/it
Priority to HU95P/P00716P priority patent/HU211855A9/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Nuovo uso dei derivati dell'acido benzimidazolin-2-oxo-1-carbossilico e loro sali di addizione con acidi fisiologicamente accettabili e loro solvati nel trattamento di disturbi mentali organici, come ad esempio demenza e sindromi amnestiche. Sono pure descritte le composizioni farmaceutiche che li contengono.
ITMI911845A 1991-07-04 1991-07-04 Uso dei derivati dell'acido benzimidazolin-2-oxo-1-carbossilico. IT1250629B (it)

Priority Applications (18)

Application Number Priority Date Filing Date Title
ITMI911845A IT1250629B (it) 1991-07-04 1991-07-04 Uso dei derivati dell'acido benzimidazolin-2-oxo-1-carbossilico.
AU19381/92A AU658197B2 (en) 1991-07-04 1992-07-02 New use of benzimidazoline-2-oxo-1-carboxylic acid derivatives
IL102381A IL102381A0 (en) 1991-07-04 1992-07-02 Pharmaceutical compositions containing benzimidazoline-2-oxo-1-carboxylic acid derivatives for the treatment of organic mental diseases
DE69200948T DE69200948T2 (de) 1991-07-04 1992-07-02 Verwendung von Benzimidazolin-2-oxo-1-Carbonsäurederivaten bei der Behandlung organischer Gehirnerkrankungen.
TW081105256A TW202386B (it) 1991-07-04 1992-07-02
MX9203900A MX9203900A (es) 1991-07-04 1992-07-02 Composicion farmaceutica que comprende derivados de acido benzimidazolin-2-oxo-1-carboxilico.
EP92830346A EP0523013B1 (en) 1991-07-04 1992-07-02 Use of benzimidazoline-2-oxo-1-carboxylic acid derivatives in the treatment of organic mental diseases
AT92830346T ATE115857T1 (de) 1991-07-04 1992-07-02 Verwendung von benzimidazolin-2-oxo-1- carbonsäurederivaten bei der behandlung organischer gehirnerkrankungen.
CA002072911A CA2072911A1 (en) 1991-07-04 1992-07-02 Use of benzimidazoline-2-oxo-1-carboxylic acid derivatives
JP4175281A JPH05194216A (ja) 1991-07-04 1992-07-02 ベンゾイミダゾリン−２−オキソ−１−カルボン酸誘導体含有精神障害治療剤
DK92830346.0T DK0523013T3 (da) 1991-07-04 1992-07-02 Anvendelse af benzimidazolin-2-oxo-1-carboxylsyrederivater ved behandling af organiske mentale sygdomme
ZA924949A ZA924949B (en) 1991-07-04 1992-07-03 New use of benzimidazoline-2-oxo-1-carboxylic acid derivatives
IE217492A IE922174A1 (en) 1991-07-04 1992-07-03 New use of benzimidazoline-2-oxo-1-carboxylic acid¹derivatives
KR1019920011823A KR930001906A (ko) 1991-07-04 1992-07-03 벤즈이미다졸린-2-옥소-1-카복실산 유도체의 용도
HU9202229A HUT61462A (en) 1991-07-04 1992-07-03 Process for producing new pharmaceutical compositions comprising 2-oxobenzimidazoline-1-carboxylic acid derivatives
NO92922635A NO922635L (no) 1991-07-04 1992-07-03 Ny anvendelse av benzimidazolin-2-okso-1-karboksylsyrederivater
GR950400566T GR3015413T3 (en) 1991-07-04 1995-03-13 Use of benzimidazoline-2-oxo-1-carboxylic acid derivatives in the treatment of organic mental diseases.
HU95P/P00716P HU211855A9 (en) 1991-07-04 1995-06-30 New use of benzimidazoline-2-oxo-1-carboxylic acid derivatives and pharmaceutical compositions containing these compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI911845A IT1250629B (it) 1991-07-04 1991-07-04 Uso dei derivati dell'acido benzimidazolin-2-oxo-1-carbossilico.

Publications (3)

Publication Number Publication Date
ITMI911845A0 ITMI911845A0 (it) 1991-07-04
ITMI911845A1 ITMI911845A1 (it) 1993-01-04
IT1250629B true IT1250629B (it) 1995-04-21

Family

ID=11360276

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI911845A IT1250629B (it) 1991-07-04 1991-07-04 Uso dei derivati dell'acido benzimidazolin-2-oxo-1-carbossilico.

Country Status (17)

Country Link
EP (1) EP0523013B1 (it)
JP (1) JPH05194216A (it)
KR (1) KR930001906A (it)
AT (1) ATE115857T1 (it)
AU (1) AU658197B2 (it)
CA (1) CA2072911A1 (it)
DE (1) DE69200948T2 (it)
DK (1) DK0523013T3 (it)
GR (1) GR3015413T3 (it)
HU (2) HUT61462A (it)
IE (1) IE922174A1 (it)
IL (1) IL102381A0 (it)
IT (1) IT1250629B (it)
MX (1) MX9203900A (it)
NO (1) NO922635L (it)
TW (1) TW202386B (it)
ZA (1) ZA924949B (it)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2699794B2 (ja) * 1992-03-12 1998-01-19 三菱化学株式会社 チエノ〔３，２−ｂ〕ピリジン誘導体
JPH05310732A (ja) * 1992-03-12 1993-11-22 Mitsubishi Kasei Corp シンノリン−３−カルボン酸誘導体
AU1734401A (en) * 1999-12-09 2001-06-18 Mitsubishi Pharma Corporation Carboxyamido derivatives
EP1861377B1 (en) * 2005-03-15 2010-12-29 Pfizer, Inc. Benzimidazolone derivatives as cb2 receptor ligands

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4605652A (en) * 1985-02-04 1986-08-12 A. H. Robins Company, Inc. Method of enhancing memory or correcting memory deficiency with arylamido (and arylthioamido)-azabicycloalkanes
US4985437A (en) * 1986-12-17 1991-01-15 Glaxo Group Limited Medicaments
IT1231413B (it) * 1987-09-23 1991-12-04 Angeli Inst Spa Derivati dell'acido benzimidazolin-2-osso-1-carbossilico utili come antagonisti dei recettori 5-ht
US4887422A (en) * 1988-09-06 1989-12-19 Amsted Industries Incorporated Rope with fiber core and method of forming same

Also Published As

Publication number Publication date
GR3015413T3 (en) 1995-06-30
DK0523013T3 (da) 1995-05-08
DE69200948D1 (de) 1995-02-02
HU9202229D0 (en) 1992-10-28
IL102381A0 (en) 1993-01-14
ZA924949B (en) 1994-01-03
AU1938192A (en) 1993-01-07
EP0523013A3 (en) 1993-01-27
AU658197B2 (en) 1995-04-06
NO922635L (no) 1993-01-05
ITMI911845A1 (it) 1993-01-04
JPH05194216A (ja) 1993-08-03
MX9203900A (es) 1993-01-01
ATE115857T1 (de) 1995-01-15
IE922174A1 (en) 1993-01-13
HU211855A9 (en) 1995-12-28
NO922635D0 (no) 1992-07-03
EP0523013B1 (en) 1994-12-21
TW202386B (it) 1993-03-21
DE69200948T2 (de) 1995-05-18
HUT61462A (en) 1993-01-28
KR930001906A (ko) 1993-02-22
ITMI911845A0 (it) 1991-07-04
EP0523013A2 (en) 1993-01-13
CA2072911A1 (en) 1993-01-05

Similar Documents

Publication Publication Date Title
AU649421B2 (en) Isoxazole-4-carboxamides and hydroxyalkylidene-cyanoacetamides, drugs containing these compounds and use of such drugs
NZ247201A (en) Substituted sulphonylamido- or sulphonamidocarbonyl-pyridine-2-carboxamide derivatives and pharmaceutical compositions
PL262105A1 (en) The method of manufacture of new derivatives of benzimidazole
IT1256450B (it) Esteri nitrici con attivita' farmacologica e procedimento per la loro preparazione
IS1904B (is) Hliðstæðar aðferðir við framleiðslu á nýjum (R)-5-karbamóýl-8-flúor-3-N,N-tvíútskiptum-amínó-3,4-díhýdró-2H-1-bensópýrönum
IT1254915B (it) Derivati di adenosina ad attivita' a2 agonista
ATE163923T1 (de) 25-carbonsäure-derivate in der vitamin d-reihe, diese derivate enthaltende pharmazeutische präparate sowie deren verwendung zur herstellung von arzneimitteln
EP0138464A3 (en) 2-amino-5-hydroxy-4-methylpyrimidine derivatives
NO940523D0 (no) Nye pyrazin-derivater
PH25130A (en) 4-acylphenoxy derivatives as anti-inflammatory agents
ATE22532T1 (de) Pharmazeutische zusammensetzung.
MX9301157A (es) Derivados de bencimidazolona, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
IT1256623B (it) Antagonisti delle tachichinine, procedimento per la loro preparazione e loro impiego in formulazioni farmaceutiche
FI891210A0 (fi) Tiosulfinsyraderivat, deras anvaendning vid inflammationssjukdomar samt laekemedel innehaollande dessa aemnen.
RU94000064A (ru) Новые 2-циано-3-гидроксипропенамиды, метод их получения и содержащие их фармацевтические композиции
AU658197B2 (en) New use of benzimidazoline-2-oxo-1-carboxylic acid derivatives
ES2105815T3 (es) Nuevos derivados de hidrazino- e hidroxiamino-14beta-hidroxiandrostano activos sobre el sistema cardiovascular, procesos para su preparacion y composiciones farmaceuticas que contienen los mismos.
ATE130841T1 (de) Ursane derivate, ihre herstellung und die enthaltende pharmazeutische zusammensetzung.
ES2145541T3 (es) Nuevos seco-d-esteroides activos sobre el sistema cardiovascular, procedimientos para su preparacion y composiciones farmaceuticas que los contienen.
IT1247508B (it) Composizioni farmaceutiche contenenti l'estere 4-(2 metilamminoetil)- 1,2- fenilenicodell`acido 2-metilpropanoico per il trattamento della neurootticopatia glaucomatosa
IT1227158B (it) Esteri dell'acido tiamorfolinone carbossilico e di suoi derivati, loro procedimento di preparazione e loro impiego nel settore cosmetico e nel settore dermo farmaceutico.
ITMI913398A1 (it) Derivati dell'eserolina ad attivita' anticolinesterasica procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
ITMI911842A1 (it) Derivati dell'eseridina utili per il trattamento delle malattie associate a disordini colinergici, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
ITMI911713A1 (it) Derivati dell'eseridina utili per il trattamento delle malattie associate a disordini colinergici, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19950629